ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 649664 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 649664; 2) Community: the network communities that were significantly associated with the response to NSC 649664; 3) Molecule: the relationships between components within communities and NSC 649664; 4) MDR: the compounds that were significantly associated with the NSC 649664.

NSC Compound Enrichment Correlation
NSC 319947 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- 0.00211131723826697 0.34060925
NSC 359415 Null 0.00211131723826697 0.29126833
NSC 608984 Leucinostatine D 0.00211131723826697 0.2359305
NSC 618770 Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide 0.00211131723826697 0.26087094
NSC 136468 Null 0.00216534295403404 0.037331344
NSC 169774 Bromocriptine methanesulfonate 0.00216534295403404 0.11166281
NSC 294979 BLEOMYCIN-BAPP 0.00216534295403404 -0.099489814
NSC 632831 Null 0.00216534295403404 0.34634009
NSC 641233 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- 0.00216534295403404 0.35340646
NSC 684459 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 4-(4-bromo- phenyl)-5,6-dihydro-2-phenyl- 0.00216534295403404 -0.32521684
Total:131  Current:14    [First] [Prev] [Next] [Last]